发明名称 5-SUBSTITUTED QUINOLINE AND ISOQUINOLINE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS ANTIPHLOGISTICS
摘要 <p>5-Substituted quinoline and isoquinoline derivatives (A) and their racemates, individual stereoisomers, enantiomers, salts and prodrugs are new. 5-Substituted quinoline and isoquinoline derivatives (A) of formula (IIa) or (IIb) and their racemates, individual stereoisomers, enantiomers, salts and prodrugs are new. R 1>, R 2>H, 1-3C alkyl, halo, CN, 1-3C alkoxy or OH. An independent claim is also included for the preparation of (A). [Image] ACTIVITY : Antiinflammatory; Respiratory-Gen.; Antirheumatic; Immunosuppressive; Antiallergic; Vasotropic, Dermatological; Antipsoriatic; Antipruritic; Nephrotropic; Hepatotropic; Gastrointestinal-Gen.; Ophthalmological; Auditory; Neuroprotective; Antibacterial; Cytostatic; Endocrine-Gen.; Antithyroid; Analgesic; Antidiabetic; CNS-Gen.; Cardiovascular-Gen.; Antiemetic; Hemostatic. MECHANISM OF ACTION : Glucocorticoid receptor binder; Steroid hormone receptor binder; Androgen receptor binder; Mineralocorticoid receptor binder; Progesterone receptor binder; Cytokine secretion inhibitor. The ability of (A) to inhibit lipopolysaccharide induced cytokine interleukin-8 secretion was tested in human monocyte cell line THP-1. The results showed that the median inhibitory concentration of 5-[4-(5-fluoro-2,3-dihydrobenzofuran-7-yl)-2-hydroxy-4-methylI-2-trifluoromethylpentylamino]-2-methylquinoline (II') was 5.9 nM.</p>
申请公布号 SI1844039(T1) 申请公布日期 2009.12.31
申请号 SI20050030792T 申请日期 2005.11.11
申请人 BAYER SCHERING PHARMA AKTIENGESELLSCHAFT 发明人 JAROCH STEFAN;REHWINKEL HARTMUT;SCHACKE HEIKE;SCHMEES NORBERT;SKUBALLA WERNER;SCHNEIDER MATTHIAS;HUBNER JAN;PETROV ORLIN;DINTER CHRISTIAN
分类号 主分类号
代理机构 代理人
主权项
地址